[Evaluation of the anticestodal activity of marnatol].
Mikhaĭlitsyn
F S
FS
Gitsu
G A
GA
D000284:Administration, Oral; D000818:Animals; D000923:Anticestodal Agents / Q000008:administration & dosage* / Q000138:chemical synthesis / Q000737:chemistry; D004353:Drug Evaluation, Preclinical; D006925:Hymenolepiasis / Q000188:drug therapy*; D048189:Hymenolepis nana; D051379:Mice; D010879:Piperazines / Q000008:administration & dosage* / Q000138:chemical synthesis / Q000737:chemistry; D011804:Quinolines / Q000008:administration & dosage* / Q000138:chemical synthesis / Q000737:chemistry
C520398:2,6-dimethyl-4-(4-(4-methylpiperazinyl-1)phenylamino)quinoline; D000923:Anticestodal Agents; D010879:Piperazines; D011804:Quinolines